Norrin



Norrin

S1SS1D2DD2P3PP3R4RR4R5RR5C6CC6M7MM7R8RR8H9HH9H10HH10Y11YY11V12VV12D13DD13S14SS14I15II15S16SS16H17HH17P18PP18L19LL19Y20YY20K21KK21C22CC22S23SS23S24SS24K25KK25M26MM26V27VV27L28LL28L29LL29A30AA30R31RR31C32CC32E33EE33G34GG34H35HH35C36CC36S37SS37Q38QQ38A39AA39S40SS40R41RR41S42SS42E43EE43P44PP44L45LL45V46VV46S47SS47... and 53 more residue(s)...... and 53 more residue(s)

SMILES None
InChIKey None
Sequence SDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 8WVY 8WVX

No bioactivity data available.

Norrin

S1SS1D2DD2P3PP3R4RR4R5RR5C6CC6M7MM7R8RR8H9HH9H10HH10Y11YY11V12VV12D13DD13S14SS14I15II15S16SS16H17HH17P18PP18L19LL19Y20YY20K21KK21C22CC22S23SS23S24SS24K25KK25M26MM26V27VV27L28LL28L29LL29A30AA30R31RR31C32CC32E33EE33G34GG34H35HH35C36CC36S37SS37Q38QQ38A39AA39S40SS40R41RR41S42SS42E43EE43P44PP44L45LL45V46VV46S47SS47... and 53 more residue(s)...... and 53 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 8WVY 8WVX

Compound is not listed as a drug.